Azargen Biotechnologies

Developing human therapeutic proteins using advanced genetic engineering and synthetic biology techniques in plants.

placeCape Town, Western Cape, South Africa calendar_todayFounded 2003 groups4 employees language azargen.com

Innovation

2 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 165 times.

YearFilings
20141
20152
20162
20172
20201

Investor mix

3 investors on record.

Investor typeCountShare
Other / undisclosed3100%
Coming soon